{"id":"arxiv/2607.07261","url":"https://arxiv.org/abs/2607.07261","tags":["math.DS"],"score":0,"title":"Mathematical models for CAR T immunotherapy and CD19 dynamics in leukemia: a comparative analysis","domain":"math.DS","source":"arxiv","authors":["Salvador Chulián","Ana Niño-López","Rocío Picón-González","María Rosa"],"reviews":0,"subject":"math.DS","summary":"Chimeric Antigen Receptor (CAR) T cell therapy has emerged as a successful treatment for relapsed or refractory hematological malignancies, particularly for B cell Acute Lymphoblastic Leukemia (B ALL), where CD19 targeted therapies have achieved high initial remission rates. However, relapse after treatment remains a major clinical challenge, frequently associated with antigen escape mechanisms and the emergence of CD19$^-$ leukemic cells. Understanding the interaction between CAR T cells and antigen expression dynamics is, therefore, essential for improving therapeutic efficacy and…","category":"research","comments":0,"disputed":false,"division":"math","mentions":0,"discussed":0,"published":"2026-07-08","reactions":{}}